news

saibogao's parent company builds global r&d capabilities to create innovative probiotic solutions for children's height intervention

2024-09-26

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

saibogao is a probiotic brand under zhongke weizhi (beijing) biotechnology co., ltd., focusing on children's height management and health services. as an innovative high-tech enterprise dedicated to improving human health with microorganisms, zhongke weizhi has accumulated nearly 10 years of scientific research and technology, and now has a unique, world-leading, and large number of independent intellectual property strains. the company also has the mgblab bacteria gut brain laboratory with independent intellectual property rights for high-throughput anaerobic strain separation, screening and preparation technology. it has not only reached strategic partnerships with many scientific research and medical institutions at home and abroad, but also established global r&d centers in the united states and denmark, with independent and complete live bacterial preparations from strains to products. r&d capabilities.
relying on the scientific and technological research and development strength of the mgblab bacteria gut brain laboratory, saibungo has quickly emerged in related fields through innovative probiotic technology, especially in product development, product layout, technology platform and production system construction based on iit clinical trials. it has made remarkable achievements and is committed to providing new solutions for children's growth and development. at present, the brand has launched products such as bl-11™ saibungo® probiotic oil drops to fulfill its commitment to the healthy growth of children and bring a new health management experience to consumers and maternal and child stores.
with its excellent product quality and brand influence, saibugao has won wide recognition in the industry. at the hfic healthy china · 2022 nutrition and health food conference and the 2022 national nutrition and health food science and technology innovation selection of china science and technology co-creation (approved by relevant departments of the ministry of science and technology), saibugao was successfully rated as an innovative product in the healthy china · nutrition and health industry by virtue of its superior technological innovation strength and outstanding transformation of scientific and technological achievements.
at the "chinagut 2023 intestinal conference", saibogao's parent company, zhongke weizhi, as a "new force" in the intestinal industry, participated in this event in all aspects. dr. duan yunfeng, founder and chief scientist of zhongke weizhi, was invited to attend the opening ceremony and was interviewed by people's daily online as a think tank expert of this china intestinal conference. in the co-organized focus academic branch of this year-the gut-brain axis conference, zhongke weizhi also relied on the company's innovative contribution to the industry-saibogao bl11 probiotic oil drops for non-drug intervention to safely increase children's height and blue cuckoo lr99 probiotic active freeze-dried powder for improving and relieving the core symptoms of autism in children. it won the 2022-2023 "intestinal industry" annual list "annual microecological innovation model enterprise".
in july 2024, saibungo made its debut at 2024cbme, and continued to innovate on the user side to enhance the knowledge and participation of new maternal and infant consumers in the popularization of probiotics for growth. as a well-known "barometer" in the industry, cbme focuses on displaying new research results and projects in the industry. during this exhibition, the saibungo booth attracted expert representatives and other professional visitors from all over the country to stop and inquire, and exchange topics related to the "bacteria-gut-brain axis". as an innovative probiotic solution for intervening in children's height, bl-11™ saibungo® probiotic oil drops made their grand debut under the witness of professionals and consumers at the cbme exhibition.
edited by: rwzh4
report/feedback